HBM Healthcare Investments (FRA:5H5A) ROCE %: % (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5H5A HBM Healthcare Investments Ltd FRA:5H5A
31 GF Score
Price €164.80
! 6 Warning Signs
View Full Analysis

What is HBM Healthcare Investments ROCE %?

HBM Healthcare Investments FRA:5H5A 31 ROCE % is % as of Mar. 2026. GuruFocus rates FRA:5H5A with a GF Score™ of 31/100. The stock has 6 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

FRA:5H5A
31GF Score
HBM Healthcare Investments Ltd FRA:5H5A
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
HBM Healthcare Investments (FRA:5H5A) has a ROCE % of % as of Mar. 2026.
Is HBM Healthcare Investments' ROCE % too high?
HBM Healthcare Investments' current ROCE % is %. Overall, HBM Healthcare Investments has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' ROCE % compare to BLK and BX?
HBM Healthcare Investments' ROCE % of % can be compared against companies in the Asset Management industry. The industry median ROCE % is 4.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Asset Management company?
The median ROCE % among Asset Management companies is 4.36, based on 711 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Asset Management industry, the median ROCE % is 4.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HBM Healthcare Investments's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (FRA:5H5A) has a current ROCE % of %. The current ROCE % is %. HBM Healthcare Investments' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For HBM Healthcare Investments (FRA:5H5A), the current ROCE % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HBM Healthcare Investments Business Description

Address Bundesplatz 1, Zug, CHE, 6300
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
31GF Score

Get the complete analysis for FRA:5H5A

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€164.80
Price